Moderna, Inc. vs Solaredge Technologies Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Solaredge Technologies Inc trades at $50.15 (market cap $2.96B). The key difference: Moderna, Inc. is far larger — about 8× Solaredge Technologies Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SEDG | |
|---|---|---|
Market Cap | $23.60B | $2.96B |
Sector | Health | Technology |
52-Week High | $81.80 | $78.51 |
52-Week Low | $22.36 | $24.42 |
Enterprise Value | $19.70B | $2.89B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →